In Indianapolis, Indiana, several hospitals and medical centers administer Keytruda (pembrolizumab), a checkpoint inhibitor used in the treatment of various cancers such as melanoma, lung cancer, head and neck cancer, and more. Some prominent facilities include
1. IU Health Simon Cancer Center: This is part of Indiana University Health and is a major cancer treatment center. It offers a comprehensive range of cancer therapies, including Keytruda, thanks to its access to the latest research and clinical trials.
2. Eskenazi Health: Eskenazi is known for its comprehensive cancer care services and is committed to providing advanced treatment options, including immunotherapy treatments like Keytruda.
3. Franciscan Health: With multiple locations in and around Indianapolis, Franciscan Health offers a variety of cancer treatment options. Their oncology departments may also provide Keytruda as part of individualized cancer treatment plans.
4. Community Health Network: This network includes several hospitals and outpatient facilities that provide cancer care. Physicians associated with Community Health Network may offer Keytruda as part of their cancer treatment regimens.
These institutions typically have a team of oncologists who evaluate patients for eligibility for Keytruda and create personalized treatment plans. If you're considering Keytruda therapy, it's important to consult with a healthcare professional to discuss options, potential benefits, and any eligibility requirements.
Before proceeding, reaching out directly to these hospitals or your healthcare provider for the most current information and to confirm the availability of Keytruda is advisable, as clinical offerings may change frequently.